Cryofocus Medtech (Shanghai) Co., Ltd.

Equities

6922

CNE100005MV5

Pharmaceuticals

Market Closed - Hong Kong S.E. 09:08:17 17/05/2024 BST 5-day change 1st Jan Change
7.29 HKD -2.93% Intraday chart for Cryofocus Medtech (Shanghai) Co., Ltd. -7.72% -61.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cryofocus Medtech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cryofocus Medtech Gets Marketing Approval in China for Cryoadhesion System MT
Cryofocus Medtech Secures Manufacturing Certification MT
Cryofocus Medtech Co., Ltd. Obtains Approval for Manufacturing Its Atrial Fibrillation Cryoablation System CI
Certain H Shares of Cryofocus Medtech Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-DEC-2023. CI
China's Medical Products Administrator Approves Cryofocus Medtech's Cryotherapy Equipment MT
Cryofocus Medtech Co., Ltd. Announces NMPA Approval for Accepting Cryoadhesion System CI
Cryofocus Medtech’s AF Cryoablation System Wins Marketing Approval in China MT
Chinese Regulator Green Lights 2 Components of Cryofocus Medtech’s Atrial Fibrillation System MT
Cryofocus Medtech Co., Ltd. Announces Nmpa Approval for Key Components of Atrial Fibrillation Cryoablation System CI
Cryofocus Medtech's Loss Widens in H1 MT
Cryofocus Medtech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Cryofocus Medtech Co., Ltd. Appoints Liu Wei as Executive Director CI
Cryofocus Medtech’s Supervisory Board Chair Resigns; Successor Named MT
Cryofocus Medtech Co., Ltd. Announces Executive Changes CI
Cryofocus Medtech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Cryofocus Medtech Co., Ltd. Announces the Resignation of Sun Xiaolu as Non-Executive Director CI
Cryofocus Medtech Co., Ltd. has completed an IPO in the amount of HKD 209.979 million. CI
Cryofocus Medtech Co., Ltd. has filed an IPO in the amount of HKD 209.979 million. CI
Chart Cryofocus Medtech (Shanghai) Co., Ltd.
More charts
Cryofocus Medtech Shanghai Co Ltd is a China-based medical device company, focusing on the research, development and commercialization of cryotherapy devices. The Company has built a comprehensive product portfolio comprising two core products, approximately 15 other product candidates in various development stages as well as approximately six additional commercialized medical consumables. The two core products comprise the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Company's products mainly target two therapeutic areas: natural orifice transluminal endoscopic surgery, to treat urinary, respiratory, and digestive diseases (such as bladder cancer, COPD, asthma, airway stenosis, gastric cancer, esophageal cancer and others), and vascular interventional therapy to treat cardiovascular diseases (such as atrial fibrillation, hypertension and others).
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.748 CNY
Average target price
25.57 CNY
Spread / Average Target
+278.94%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6922 Stock
  4. News Cryofocus Medtech (Shanghai) Co., Ltd.
  5. Cryofocus Medtech Gets Marketing Approval in China for Cryoadhesion System